Skip to main content
Erschienen in: Digestive Diseases and Sciences 8/2006

01.08.2006 | Original Paper

A Very Low-Carbohydrate Diet Improves Gastroesophageal Reflux and Its Symptoms

verfasst von: Gregory L. Austin, Michelle T. Thiny, Eric C. Westman, William S. Yancy Jr., Nicholas J. Shaheen

Erschienen in: Digestive Diseases and Sciences | Ausgabe 8/2006

Einloggen, um Zugang zu erhalten

Abstract

Obese patients with gastroesophageal reflux disease (GERD) may experience resolution of symptoms utilizing a very low-carbohydrate diet. The mechanism of this improvement is unknown. This studied aimed to prospectively assess changes in distal esophageal acid exposure and GERD symptoms among obese adults initiating a very low-carbohydrate diet. We studied obese individuals with GERD initiating a diet containing less than 20 g/day of carbohydrates. Symptom severity was assessed using the GERD Symptom Assessment Scale—Distress Subscale (GSAS-ds). Participants underwent 24-hr esophageal pH probe testing and initiated the diet upon its completion. Within 6 days, a second pH probe test was performed. Outcomes included changes in the Johnson-DeMeester score, percentage total time with a pH<4 in the distal esophagus, and GSAS-ds scores. Eight participants were enrolled. Mean Johnson-DeMeester score decreased from 34.7 to 14.0 (P=0.023). Percentage time with pH<4 decreased from 5.1% to 2.5% (P=0.022). Mean GSAS-ds score decreased from 1.28 to 0.72 (P=0.0004). These data suggest that a very low-carbohydrate diet in obese individuals with GERD significantly reduces distal esophageal acid exposure and improves symptoms.
Literatur
1.
Zurück zum Zitat Locke GR 3rd, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ 3rd (1997) Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 112(5):1448–1456PubMedCrossRef Locke GR 3rd, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ 3rd (1997) Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 112(5):1448–1456PubMedCrossRef
2.
Zurück zum Zitat Sandler RS, Everhart JE, Donowitz M, et al. (2002) The burden of selected digestive diseases in the United States. Gastroenterology 122(5):1500–1511PubMedCrossRef Sandler RS, Everhart JE, Donowitz M, et al. (2002) The burden of selected digestive diseases in the United States. Gastroenterology 122(5):1500–1511PubMedCrossRef
3.
Zurück zum Zitat Locke GR 3rd, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ 3rd (1999) Risk factors associated with symptoms of gastroesophageal reflux. Am J Med 106(6):642–649PubMedCrossRef Locke GR 3rd, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ 3rd (1999) Risk factors associated with symptoms of gastroesophageal reflux. Am J Med 106(6):642–649PubMedCrossRef
4.
Zurück zum Zitat Nandurkar S, Locke GR, 3rd, Fett S, Zinsmeister AR, Cameron AJ, Talley NJ (2004) Relationship between body mass index, diet, exercise and gastro-oesophageal reflux symptoms in a community. Aliment Pharmacol Ther 20(5):497–505PubMedCrossRef Nandurkar S, Locke GR, 3rd, Fett S, Zinsmeister AR, Cameron AJ, Talley NJ (2004) Relationship between body mass index, diet, exercise and gastro-oesophageal reflux symptoms in a community. Aliment Pharmacol Ther 20(5):497–505PubMedCrossRef
5.
Zurück zum Zitat Tutuian R, Castell DO (2003) Management of gastroesophageal reflux disease. Am J Med Sci 326(5):309–318PubMedCrossRef Tutuian R, Castell DO (2003) Management of gastroesophageal reflux disease. Am J Med Sci 326(5):309–318PubMedCrossRef
6.
Zurück zum Zitat Kjellin A, Ramel S, Rossner S, Thor K (1996) Gastroesophageal reflux in obese patients is not reduced by weight reduction. Scand J Gastroenterol 31(11):1047–1051PubMedCrossRef Kjellin A, Ramel S, Rossner S, Thor K (1996) Gastroesophageal reflux in obese patients is not reduced by weight reduction. Scand J Gastroenterol 31(11):1047–1051PubMedCrossRef
7.
Zurück zum Zitat Meining A, Classen M (2000) The role of diet and lifestyle measures in the pathogenesis and treatment of gastroesophageal reflux disease. Am J Gastroenterol 95(10):2692–2697PubMedCrossRef Meining A, Classen M (2000) The role of diet and lifestyle measures in the pathogenesis and treatment of gastroesophageal reflux disease. Am J Gastroenterol 95(10):2692–2697PubMedCrossRef
8.
Zurück zum Zitat DeVault KR, Castell DO (2005) Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol 100(1):190–200PubMedCrossRef DeVault KR, Castell DO (2005) Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol 100(1):190–200PubMedCrossRef
9.
Zurück zum Zitat Fraser-Moodie CA, Norton B, Gornall C, Magnago S, Weale AR, Holmes GK (1999) Weight loss has an independent beneficial effect on symptoms of gastro-oesophageal reflux in patients who are overweight. Scand J Gastroenterol 34(4):337–40PubMedCrossRef Fraser-Moodie CA, Norton B, Gornall C, Magnago S, Weale AR, Holmes GK (1999) Weight loss has an independent beneficial effect on symptoms of gastro-oesophageal reflux in patients who are overweight. Scand J Gastroenterol 34(4):337–40PubMedCrossRef
10.
Zurück zum Zitat Yancy WS, Jr., Provenzale D, Westman EC (2001) Improvement of gastroesophageal reflux disease after initiation of a low-carbohydrate diet: five brief case reports. Altern Ther Health Med 7(6):120, 116–119PubMed Yancy WS, Jr., Provenzale D, Westman EC (2001) Improvement of gastroesophageal reflux disease after initiation of a low-carbohydrate diet: five brief case reports. Altern Ther Health Med 7(6):120, 116–119PubMed
11.
Zurück zum Zitat Rothman M, Farup C, Stewart W, Helbers L, Zeldis J (2001) Symptoms associated with gastroesophageal reflux disease: development of a questionnaire for use in clinical trials. Dig Dis Sci 46(7):1540–1549PubMedCrossRef Rothman M, Farup C, Stewart W, Helbers L, Zeldis J (2001) Symptoms associated with gastroesophageal reflux disease: development of a questionnaire for use in clinical trials. Dig Dis Sci 46(7):1540–1549PubMedCrossRef
12.
Zurück zum Zitat Damiano A, Handley K, Adler E, Siddique R, Bhattacharyja A (2002) Measuring symptom distress and health-related quality of life in clinical trials of gastroesophageal reflux disease treatment: further validation of the Gastroesophageal Reflux Disease Symptom Assessment Scale (GSAS). Dig Dis Sci 47(7):1530–1537PubMedCrossRef Damiano A, Handley K, Adler E, Siddique R, Bhattacharyja A (2002) Measuring symptom distress and health-related quality of life in clinical trials of gastroesophageal reflux disease treatment: further validation of the Gastroesophageal Reflux Disease Symptom Assessment Scale (GSAS). Dig Dis Sci 47(7):1530–1537PubMedCrossRef
13.
Zurück zum Zitat Weusten B, Smout A (2004) Ambulatory monitoring of esophageal pH and pressure. In: Castell D, Richter J (eds) The esophagus, 4th ed. Lippincott, Williams, & Wilkins, Philadelphia, PA, pp 136–150 Weusten B, Smout A (2004) Ambulatory monitoring of esophageal pH and pressure. In: Castell D, Richter J (eds) The esophagus, 4th ed. Lippincott, Williams, & Wilkins, Philadelphia, PA, pp 136–150
14.
Zurück zum Zitat Johnson LF, Demeester TR (1974) Twenty-four-hour pH monitoring of the distal esophagus. A quantitative measure of gastroesophageal reflux. Am J Gastroenterol 62(4):325–332PubMed Johnson LF, Demeester TR (1974) Twenty-four-hour pH monitoring of the distal esophagus. A quantitative measure of gastroesophageal reflux. Am J Gastroenterol 62(4):325–332PubMed
15.
Zurück zum Zitat Streets CG, DeMeester TR (2003) Ambulatory 24-hr esophageal pH monitoring: why, when, and what to do. J Clin Gastroenterol 37(1):14–22PubMedCrossRef Streets CG, DeMeester TR (2003) Ambulatory 24-hr esophageal pH monitoring: why, when, and what to do. J Clin Gastroenterol 37(1):14–22PubMedCrossRef
16.
Zurück zum Zitat Swiatkowski M, Budzynski J, Klopocka M, et al. (2004) The effect of eight weeks of rabeprazole therapy on nitric oxide plasma level and esophageal pH and motility and motility nitric oxide plasma level in patients with erosive esophagitis. Med Sci Monit 10(2):CR46–CR51PubMed Swiatkowski M, Budzynski J, Klopocka M, et al. (2004) The effect of eight weeks of rabeprazole therapy on nitric oxide plasma level and esophageal pH and motility and motility nitric oxide plasma level in patients with erosive esophagitis. Med Sci Monit 10(2):CR46–CR51PubMed
17.
Zurück zum Zitat Ladas SD, Tassios PS, Raptis SA (2000) Selection of patients for successful maintenance treatment of esophagitis with low-dose omeprazole: use of 24-hr gastric pH monitoring. Am J Gastroenterol 95(2):374–380PubMed Ladas SD, Tassios PS, Raptis SA (2000) Selection of patients for successful maintenance treatment of esophagitis with low-dose omeprazole: use of 24-hr gastric pH monitoring. Am J Gastroenterol 95(2):374–380PubMed
18.
Zurück zum Zitat Stern L, Iqbal N, Seshadri P, et al. (2004) The effects of low-carbohydrate versus conventional weight loss diets in severely obese adults: one-year follow-up of a randomized trial. Ann Intern Med 140(10):778–785PubMed Stern L, Iqbal N, Seshadri P, et al. (2004) The effects of low-carbohydrate versus conventional weight loss diets in severely obese adults: one-year follow-up of a randomized trial. Ann Intern Med 140(10):778–785PubMed
19.
Zurück zum Zitat Yancy WS Jr, Olsen MK, Guyton JR, Bakst RP, Westman EC (2004) A low-carbohydrate, ketogenic diet versus a low-fat diet to treat obesity and hyperlipidemia: a randomized, controlled trial. Ann Intern Med 140(10):769–777PubMed Yancy WS Jr, Olsen MK, Guyton JR, Bakst RP, Westman EC (2004) A low-carbohydrate, ketogenic diet versus a low-fat diet to treat obesity and hyperlipidemia: a randomized, controlled trial. Ann Intern Med 140(10):769–777PubMed
20.
Zurück zum Zitat El-Serag HB, Satia JA, Rabeneck L (2005) Dietary intake and the risk of gastro-oesophageal reflux disease: a cross sectional study in volunteers. Gut 54(1):11–17PubMedCrossRef El-Serag HB, Satia JA, Rabeneck L (2005) Dietary intake and the risk of gastro-oesophageal reflux disease: a cross sectional study in volunteers. Gut 54(1):11–17PubMedCrossRef
21.
Zurück zum Zitat Wiener GJ, Morgan TM, Copper JB, et al. (1988) Ambulatory 24-hr esophageal pH monitoring. Reproducibility and variability of pH parameters. Dig Dis Sci 33(9):1127–1133PubMedCrossRef Wiener GJ, Morgan TM, Copper JB, et al. (1988) Ambulatory 24-hr esophageal pH monitoring. Reproducibility and variability of pH parameters. Dig Dis Sci 33(9):1127–1133PubMedCrossRef
22.
Zurück zum Zitat Vaezi MF, Schroeder PL, Richter JE (1997) Reproducibility of proximal probe pH parameters in 24-hr ambulatory esophageal pH monitoring. Am J Gastroenterol 92(5):825–829PubMed Vaezi MF, Schroeder PL, Richter JE (1997) Reproducibility of proximal probe pH parameters in 24-hr ambulatory esophageal pH monitoring. Am J Gastroenterol 92(5):825–829PubMed
23.
Zurück zum Zitat Piche T, Zerbib F, Varannes SB, et al. (2000) Modulation by colonic fermentation of LES function in humans. Am J Physiol Gastrointest Liver Physiol 278(4):G578–G584PubMed Piche T, Zerbib F, Varannes SB, et al. (2000) Modulation by colonic fermentation of LES function in humans. Am J Physiol Gastrointest Liver Physiol 278(4):G578–G584PubMed
24.
Zurück zum Zitat Piche T, des Varannes SB, Sacher-Huvelin S, Holst JJ, Cuber JC, Galmiche JP (2003) Colonic fermentation influences lower esophageal sphincter function in gastroesophageal reflux disease. Gastroenterology 124(4):894–902PubMedCrossRef Piche T, des Varannes SB, Sacher-Huvelin S, Holst JJ, Cuber JC, Galmiche JP (2003) Colonic fermentation influences lower esophageal sphincter function in gastroesophageal reflux disease. Gastroenterology 124(4):894–902PubMedCrossRef
25.
Zurück zum Zitat Clave P, Gonzalez A, Moreno A, et al. (1998) Endogenous cholecystokinin enhances postprandial gastroesophageal reflux in humans through extrasphincteric receptors. Gastroenterology 115(3):597–604PubMedCrossRef Clave P, Gonzalez A, Moreno A, et al. (1998) Endogenous cholecystokinin enhances postprandial gastroesophageal reflux in humans through extrasphincteric receptors. Gastroenterology 115(3):597–604PubMedCrossRef
26.
Zurück zum Zitat Zerbib F, Bruley DesVarannes S, et al. (1998) Endogenous cholecystokinin in postprandial lower esophageal sphincter function and fundic tone in humans. Am J Physiol 275(6, Pt 1):G1266–G1273PubMed Zerbib F, Bruley DesVarannes S, et al. (1998) Endogenous cholecystokinin in postprandial lower esophageal sphincter function and fundic tone in humans. Am J Physiol 275(6, Pt 1):G1266–G1273PubMed
27.
Zurück zum Zitat Ledeboer M, Masclee AA, Batstra MR, Jansen JB, Lamers CB (1995) Effect of cholecystokinin on lower oesophageal sphincter pressure and transient lower oesophageal sphincter relaxations in humans. Gut 36(1):39–44PubMedCrossRef Ledeboer M, Masclee AA, Batstra MR, Jansen JB, Lamers CB (1995) Effect of cholecystokinin on lower oesophageal sphincter pressure and transient lower oesophageal sphincter relaxations in humans. Gut 36(1):39–44PubMedCrossRef
28.
Zurück zum Zitat Straathof JW, Tieleman S, Lamers CB, Masclee AA (2000) Effect of somatostatin on lower esophageal sphincter characteristics in man. Scand J Gastroenterol 35(9):910–915PubMedCrossRef Straathof JW, Tieleman S, Lamers CB, Masclee AA (2000) Effect of somatostatin on lower esophageal sphincter characteristics in man. Scand J Gastroenterol 35(9):910–915PubMedCrossRef
29.
Zurück zum Zitat Lidums I, Lehmann A, Checklin H, Dent J, Holloway RH (2000) Control of transient lower esophageal sphincter relaxations and reflux by the GABA(B) agonist baclofen in normal subjects. Gastroenterology 118(1):7–13PubMedCrossRef Lidums I, Lehmann A, Checklin H, Dent J, Holloway RH (2000) Control of transient lower esophageal sphincter relaxations and reflux by the GABA(B) agonist baclofen in normal subjects. Gastroenterology 118(1):7–13PubMedCrossRef
30.
Zurück zum Zitat Stacher G, Lenglinger J, Bergmann H, et al. (2000) Gastric emptying: A contributory factor in gastro-oesophageal reflux activity? Gut 47(5):661–666PubMedCrossRef Stacher G, Lenglinger J, Bergmann H, et al. (2000) Gastric emptying: A contributory factor in gastro-oesophageal reflux activity? Gut 47(5):661–666PubMedCrossRef
31.
Zurück zum Zitat Buckles DC, Sarosiek I, McMillin C, McCallum RW (2004) Delayed gastric emptying in gastroesophageal reflux disease: reassessment with new methods and symptomatic correlations. Am J Med Sci 327(1):1–4PubMedCrossRef Buckles DC, Sarosiek I, McMillin C, McCallum RW (2004) Delayed gastric emptying in gastroesophageal reflux disease: reassessment with new methods and symptomatic correlations. Am J Med Sci 327(1):1–4PubMedCrossRef
Metadaten
Titel
A Very Low-Carbohydrate Diet Improves Gastroesophageal Reflux and Its Symptoms
verfasst von
Gregory L. Austin
Michelle T. Thiny
Eric C. Westman
William S. Yancy Jr.
Nicholas J. Shaheen
Publikationsdatum
01.08.2006
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 8/2006
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-005-9027-7

Weitere Artikel der Ausgabe 8/2006

Digestive Diseases and Sciences 8/2006 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.